Asthma as an outcome: Exploring multiple definitions of asthma across birth cohorts in the Environmental influences on Child Health Outcomes Children's Respiratory and Environmental Workgroup - 05/09/19
, Tebeb Gebretsadik, MPH b, Daniel J. Jackson, MD c, Jocelyn Biagini Myers, PhD d, e, Suzanne Havstad, MA f, Robert F. Lemanske, MD c, Tina V. Hartert, MD g, Gurjit K. Khurana Hershey, MD, PhD d, e, Edward M. Zoratti, MD h, Lisa J. Martin, PhD d, i, Rachel Miller, MD j, Diane R. Gold, MD k, l, Anne Wright, MD m, Debra A. Stern, MS m, James E. Gern, MD c, Christine C. Johnson, PhD ffor the
Children's Respiratory and Environmental Workgroup
| The Children's Respiratory and Environmental Workgroup (CREW) is funded by US Department of Health and Human Services/National Institutes of Health grants 5UG3OD023282 and 4UH3OD023282. Additional support was provided by individual cohorts' grants/contracts: Columbia University—P01ES09600, R01 ES008977, P30ES09089, R01 ES013163, and R827027; Tucson Children’s Respiratory Study (TCRS)—National Heart, Lung, and Blood Institute 132523; Infant Immune Study (IIS)—HL-56177; Childhood Origins of Asthma Study (COAST)—P01 HL070831, U10 HL064305, and R01 HL061879; Urban Environment and Childhood Asthma Study (URECA)—NO1-AI-25496, NO1-AI-25482, HHSN272200900052C, HHSN272201000052I, National Center for Research Resources/NIH RR00052, M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, UL1TR001079, 5UL1RR024992-02, and National Center for Advancing Translational Sciences (NCATS)/NIH UL1TR000040; Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS)—R01 ES11170 and R01 ES019890; Epidemiology of Home Allergens and Asthma Study (EHAAS)—R01 AI035786; Wayne County Health, Environment, Allergy and Asthma Longitudinal Study (WHEALS)—R01 AI050681, R56 AI050681, R01 AI061774, R21 AI059415, K01 AI070606, R21 AI069271, R01 HL113010, R21 ES022321, P01 AI089473, R21 AI080066, R01 AI110450, R01 HD082147, and the Fund for Henry Ford Health System; Childhood Allergy Study (CAS)—R01 AI024156, R03 HL067427, R01 AI051598, Blue Cross Foundation Johnson, and the Fund for Henry Ford Hospital. |
|
| Disclosure of potential conflict of interest: All authors report grants from the National Institutes of Health (NIH) during the conduct of the study. D. J. Jackson reports grants from GlaxoSmithKline, as well as personal fees from Novartis, Vifor Pharma, Pfizer, Boehringer Ingelheim, and Commense outside the submitted work. R. F. Lemanske reports grants as part of the Clinical and Translational Science Award from NIH, Childhood Origins of Asthma (COAST), and AsthmaNet outside the submitted work; reports personal fees from LSU, the University of Kentucky, and Thermo Fischer outside the submitted work; and reports royalties from Elsevier and UpToDate outside the submitted work. T. V. Hartert reports grants from the World Health Organization outside the submitted work. J. E. Gern reports personal fees from PREP Biopharm, Regeneron, MedImmune, and Ena Pharmaceuticals, as well as personal fees and stock options from Meissa Vaccines outside the submitted work and has a patent for “Methods of propagating rhinovirus C in previously unsusceptible cell lines” issued and a patent for “Adapted rhinovirus C” pending. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 144 - N° 3
P. 866 - septembre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
